Knight Therapeutics Inc KHTRF

BNN next week

[wofats]

Jason Donville

 

This was an analyst who started talking about Paladin Labs in the early days of the stocks rise  2008 or 2009 I believe . Here is a link to some info on his philosophy and how he evaluates stock. 

 

https://donvillekent.com/wp-content/uploads/2022/11/DKAM-ROE-Reporter-November-2022-Final.pdf

 

He has not been on  BNN in 7 years . He is slated for his comeback on Monday or Tuesday . I wonder if his opinion of Knight and the way they are building the company and its rising EBITDA is favourable. Maybe Knight will come up in his conversations . A recommendation from him would make a difference wouldn’t it?  This would either confirm or deny if Knight is on or close to that same path as Paladin was.
I am just musing in print .

I personally like the GUD story and am nibbling . Do your own DD but this does look promising and I have been holding and building a position for a while .  For sure this is not a buy and sell trade . You need patience if you are holder or plan on becoming one . 

The year results are out in 2 weeks and the first quarter ends 6 business days after that.  The company direction should be clearer after it comes out.

GL to all 

 

 

[gudisgood]

Interesting! In the short-term, our results and financial situation will be significantly influenced by a couple things: 1) Will the MOH contracts continue coming in? This will significantly affect our growth rate in the short term. 2) I assume the final decision for the tax issue will be made soon (or this year, at least), just because it has already taken quite long. Winning this would be a

[Possibleidiot01]

stockchase.com, Jason Donville DON'T BUY Knight Therapeutics(GUD-T) 12/03/2024   Years ago, they bought a major company that he owned a lot of shares in. He's waiting for another such purchase by GUD before considering it. He's looking for companies with growth and earnings. 0   N/A Not owned

[wofats]

of Issuer Holder: Armco Alberta Inc. (Control or Direction) Common Shares 10 - Acquisition or disposition in the public market $402,150 +76,600 vol $5.25 each 12,392,200   Filed 2024-03-13 13:26   Tx date 2024-03-12 $GUD Knight Therapeutics Inc. Armoyan